← Back to Screener
Apogee Therapeutics, Inc. Common Stock (APGE)
Price$86.92
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)12.85%
Price vs S&P 500 (4W)4.69%
VGM Score85.65
Market Capitalization$6.55B
All Metrics
Book Value / Share (Quarterly)$16.77
P/TBV (Annual)6.13x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-3.14
Price vs S&P 500 (YTD)7.00%
EPS (TTM)$-4.33
10-Day Avg Trading Volume1.33M
EPS Excl Extra (TTM)$-4.33
EPS (Annual)$-4.22
ROI (Annual)-25.41%
Cash / Share (Quarterly)$14.15
ROA (Last FY)-24.16%
EBITD / Share (TTM)$-4.78
Cash Flow / Share (Annual)$-2.97
P/B Ratio5.22x
P/B Ratio (Quarterly)4.96x
Net Income / Employee (Annual)$-1,000
ROA (TTM)-31.25%
EPS Incl Extra (Annual)$-4.22
Current Ratio (Annual)18.55x
Quick Ratio (Quarterly)32.42x
3-Month Avg Trading Volume0.94M
52-Week Price Return130.86%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$8.52
52-Week High$95.31
EPS Excl Extra (Annual)$-4.22
26-Week Price Return20.77%
Quick Ratio (Annual)18.29x
13-Week Price Return22.56%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)32.59x
Enterprise Value$6.10B
Revenue / Employee (Annual)$0
Cash / Share (Annual)$8.97
3-Month Return Std Dev62.61%
Net Income / Employee (TTM)$-1,100
ROE (Last FY)-25.41%
EPS Basic Excl Extra (Annual)$-4.22
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-4.33
ROI (TTM)-32.64%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$2.98
Price vs S&P 500 (52W)106.50%
Year-to-Date Return15.16%
5-Day Price Return9.61%
EPS Normalized (Annual)$-4.22
Month-to-Date Return5.82%
EBITD / Share (Annual)$-4.68
EPS Basic Excl Extra (TTM)$-4.33
P/TBV (Quarterly)2.13x
P/B Ratio (Annual)3.70x
Book Value / Share (Annual)$12.35
Price vs S&P 500 (13W)14.31%
Beta0.53x
Revenue / Share (TTM)$0.00
ROE (TTM)-32.64%
52-Week Low$34.34
mGradeA
vgmGradeA
Show chart for
Earnings Surprise History
Q1 26-1.06est. -1.12
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.32
4.26
4.26
4.20
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
APGEApogee Therapeutics, Inc. Common Stock | — | — | A | $86.92 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Apogee Therapeutics develops engineered monoclonal antibodies targeting atopic dermatitis, COPD, and other inflammatory and immunology indications with significant unmet medical need. The company's differentiated programs leverage optimized antibody engineering to overcome limitations of existing therapies by targeting validated mechanisms of action.